At this time it is unclear what the cause is of this shortage, however with the dramatic increase in the use of cobalt for electric vehicle batteries, with 40 pounds of cobalt required for each battery, this may be a potential diversion of the cobalt away from the manufacture of cobalamin (B12) for injectable vitamin
Alonso MR, Anesini C
Nuclear IGF1R interacts with regulatory regions of chromatin to promote RNA polymerase II recruitment and gene expression associated with advanced tumor stage
Tozuka Y, Fukuda S, Namba T, Seki T, Hisatsune T (2005)
Phase 2 cagrilintide alone ~10.8% body weight reduction at 26 weeks (4.5mg) Phase 2 CagriSema combo ~15.6% body weight reduction at 32 weeks Phase 3 REDEFINE 1 ~22.7% body weight reduction at 68 weeks Phase 2 CagriSema combination trial The Phase 2 trial of CagriSema was published in The Lancet in 2023, and its results attracted immediate attention
doi: 10.1016/S1874-6047(08)60245-0